These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15830705)

  • 21. IGF-independent effects of IGFBP-2 on the human breast cancer cell line Hs578T.
    Frommer KW; Reichenmiller K; Schutt BS; Hoeflich A; Ranke MB; Dodt G; Elmlinger MW
    J Mol Endocrinol; 2006 Aug; 37(1):13-23. PubMed ID: 16901920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1.
    Shetty S; Graham BA; Brown JG; Hu X; Vegh-Yarema N; Harding G; Paul JT; Gibson SB
    Mol Cell Biol; 2005 Jul; 25(13):5404-16. PubMed ID: 15964798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apoptosis-inducing effect of garcinol is mediated by NF-kappaB signaling in breast cancer cells.
    Ahmad A; Wang Z; Ali R; Maitah MY; Kong D; Banerjee S; Padhye S; Sarkar FH
    J Cell Biochem; 2010 Apr; 109(6):1134-41. PubMed ID: 20108249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death.
    Uwagawa T; Li Z; Chang Z; Xia Q; Peng B; Sclabas GM; Ishiyama S; Hung MC; Evans DB; Abbruzzese JL; Chiao PJ
    Cancer; 2007 May; 109(10):2142-53. PubMed ID: 17410536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen-activated protein kinase pathway.
    Li Z; Li J; Mo B; Hu C; Liu H; Qi H; Wang X; Xu J
    Toxicol In Vitro; 2008 Oct; 22(7):1749-53. PubMed ID: 18761399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-8 and p53 are inversely regulated through JNK, p38 and NF-kappaB p65 in HepG2 cells during an inflammatory response.
    Rasmussen MK; Iversen L; Johansen C; Finnemann J; Olsen LS; Kragballe K; Gesser B
    Inflamm Res; 2008 Jul; 57(7):329-39. PubMed ID: 18607537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions between bortezomib and romidepsin and belinostat in chronic lymphocytic leukemia cells.
    Dai Y; Chen S; Kramer LB; Funk VL; Dent P; Grant S
    Clin Cancer Res; 2008 Jan; 14(2):549-58. PubMed ID: 18223231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding.
    Van Laere SJ; Van der Auwera I; Van den Eynden GG; Elst HJ; Weyler J; Harris AL; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3249-56. PubMed ID: 16740744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cross-talk between nuclear factor-kappaB and P53 signal pathway in keratinocytes after ultraviolet B irradiation].
    Wang P; Song XZ; Bi ZG; Xu AE; Cui YG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3088-91. PubMed ID: 18261359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappaB pathways in human gastric adenocarcinoma.
    Feng W; Brown RE; Trung CD; Li W; Wang L; Khoury T; Alrawi S; Yao J; Xia K; Tan D
    Ann Clin Lab Sci; 2008; 38(3):195-209. PubMed ID: 18715846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma.
    Heider U; von Metzler I; Kaiser M; Rosche M; Sterz J; Rötzer S; Rademacher J; Jakob C; Fleissner C; Kuckelkorn U; Kloetzel PM; Sezer O
    Eur J Haematol; 2008 Feb; 80(2):133-42. PubMed ID: 18005386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting the NF-kappa B pathway in estrogen receptor negative MDA-MB-231 breast cancer cells using small inhibitory RNAs.
    Monks NR; Pardee AB
    J Cell Biochem; 2006 May; 98(1):221-33. PubMed ID: 16408291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model.
    Kang HJ; Lee SH; Price JE; Kim LS
    Breast J; 2009; 15(3):223-9. PubMed ID: 19645775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
    Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
    Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancer.
    Mortenson MM; Schlieman MG; Virudachalam S; Lara PN; Gandara DG; Davies AM; Bold RJ
    Lung Cancer; 2005 Aug; 49(2):163-70. PubMed ID: 16022909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB.
    Benoit V; de Moraes E; Dar NA; Taranchon E; Bours V; Hautefeuille A; Tanière P; Chariot A; Scoazec JY; de Moura Gallo CV; Merville MP; Hainaut P
    Oncogene; 2006 Sep; 25(42):5708-18. PubMed ID: 16682957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NF-κB localization in multiple myeloma plasma cells and mesenchymal cells.
    Conticello C; Giuffrida R; Adamo L; Anastasi G; Martinetti D; Salomone E; Colarossi C; Amato G; Gorgone A; Romano A; Iannolo G; De Maria R; Giustolisi R; Gulisano M; Di Raimondo F
    Leuk Res; 2011 Jan; 35(1):52-60. PubMed ID: 20674018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro.
    Mitsiades CS; McMillin D; Kotoula V; Poulaki V; McMullan C; Negri J; Fanourakis G; Tseleni-Balafouta S; Ain KB; Mitsiades N
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4013-21. PubMed ID: 16849420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear factor-kappaB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate.
    Sweeney C; Li L; Shanmugam R; Bhat-Nakshatri P; Jayaprakasan V; Baldridge LA; Gardner T; Smith M; Nakshatri H; Cheng L
    Clin Cancer Res; 2004 Aug; 10(16):5501-7. PubMed ID: 15328189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.